Literature DB >> 19230762

Bloodstream infections in a German paediatric oncology unit: prolongation of inpatient treatment and additional costs.

Christoph Biwersi1, Nico Hepping, Udo Bode, Gudrun Fleischhack, Anja von Renesse, Martin Exner, Steffen Engelhart, Beate Gieselmann, Arne Simon.   

Abstract

In this matched cohort study, clinical data from 43 paediatric cancer patients with bloodstream infection (BSI) were compared with 43 thoroughly matched control patients without BSI. BSI led to a median additional length of inpatient treatment of 12 days (IQR 8.5-16 days; P<0.001), accounting for median additional expenses of euro4400 (IQR, euro3145-5920) per case [6.970 US Dollar (IQR 4.938-9.294)]. Thus, BSI substantially increased financial resources required for inpatient treatment. These data compiled from a paediatric cancer unit may be utilized to estimate the cost-benefit ratio of targeted preventive measures.

Entities:  

Mesh:

Year:  2009        PMID: 19230762     DOI: 10.1016/j.ijheh.2009.01.003

Source DB:  PubMed          Journal:  Int J Hyg Environ Health        ISSN: 1438-4639            Impact factor:   5.840


  8 in total

1.  Impact of a multidimensional infection control strategy on central line-associated bloodstream infection rates in pediatric intensive care units of five developing countries: findings of the International Nosocomial Infection Control Consortium (INICC).

Authors:  V D Rosenthal; B Ramachandran; W Villamil-Gómez; A Armas-Ruiz; J A Navoa-Ng; L Matta-Cortés; M Pawar; A Nevzat-Yalcin; M Rodríguez-Ferrer; R D Yıldızdaş; A Menco; R Campuzano; V D Villanueva; L F Rendon-Campo; A Gupta; O Turhan; N Barahona-Guzmán; O O Horoz; P Arrieta; J M Brito; M C V Tolentino; Y Astudillo; N Saini; N Gunay; G Sarmiento-Villa; E Gumus; A Lagares-Guzmán; O Dursun
Journal:  Infection       Date:  2012-02-28       Impact factor: 3.553

2.  Moving CLABSI prevention beyond the intensive care unit: risk factors in pediatric oncology patients.

Authors:  Matthew Kelly; Margaret Conway; Kathleen Wirth; Gail Potter-Bynoe; Amy L Billett; Thomas J Sandora
Journal:  Infect Control Hosp Epidemiol       Date:  2011-09-20       Impact factor: 3.254

3.  Microbiology and risk factors for central line-associated bloodstream infections among pediatric oncology outpatients: a single institution experience of 41 cases.

Authors:  Matthew S Kelly; Margaret Conway; Kathleen E Wirth; Gail Potter-Bynoe; Amy L Billett; Thomas J Sandora
Journal:  J Pediatr Hematol Oncol       Date:  2013-03       Impact factor: 1.289

4.  Bloodstream infection in paediatric cancer centres--leukaemia and relapsed malignancies are independent risk factors.

Authors:  R A Ammann; H J Laws; D Schrey; K Ehlert; O Moser; D Dilloo; U Bode; A Wawer; A Schrauder; G Cario; A Laengler; N Graf; R Furtwängler; A Simon
Journal:  Eur J Pediatr       Date:  2015-03-26       Impact factor: 3.183

5.  Improving oral hygiene skills among children undergoing treatment at the haemato-oncology department - an interventional programme.

Authors:  Liran Levin; Leon Bilder; Oxana Borisov
Journal:  Int Dent J       Date:  2015-05-31       Impact factor: 2.607

Review 6.  Surveillance of bloodstream infections in pediatric cancer centers - what have we learned and how do we move on?

Authors:  Arne Simon; Rhoikos Furtwängler; Norbert Graf; Hans Jürgen Laws; Sebastian Voigt; Brar Piening; Christine Geffers; Philipp Agyeman; Roland A Ammann
Journal:  GMS Hyg Infect Control       Date:  2016-05-12

7.  Preemptive Ethanol Lock Therapy in Pediatric Hematology/Oncology Patients With Catheter-Associated Bloodstream Infection: Impact on Length of Stay, Cost, and Catheter Salvage.

Authors:  Eric McGrath; Wei Du; Madhvi Rajpurkar
Journal:  Clin Pediatr (Phila)       Date:  2017-06-30       Impact factor: 1.168

8.  Impact of a modified Broviac maintenance care bundle on bloodstream infections in paediatric cancer patients.

Authors:  Rhoikos Furtwängler; Carolin Laux; Norbert Graf; Arne Simon
Journal:  GMS Hyg Infect Control       Date:  2015-11-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.